A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Cancer
Non Hodgkin Lymphoma (NHL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Lymphoma

Results
Download
Print

Study results

LPS BO42203 Final Results May 2025 English (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 French (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 Italian (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 Spanish (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Study results

LPS BO42203 Final Results May 2025 English (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 French (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 Italian (PDF, 0.4 MB)

LPS BO42203 Final Results May 2025 Spanish (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

For the latest version of this information please go to www.forpatients.roche.com